OriGene shRNA in recent publications

Suppression of Sproutys Has a Therapeutic Effect for a Mouse Model of Ischemia by Enhancing Angiogenesis PLoS ONE. 2009; 4(5): e5467 [Spry4(in vivo application)]

RNA interference-mediated in vivo silencing of FasL as a strategy for the enhancement of DNA vaccine potency Human Gene Therapy. August 2008, 19(8): 763-773 [sh-Luc(in vivo application)]

ZIP4 Regulates Pancreatic Cancer Cell Growth by Activating IL-6/STAT3 Pathway through Zinc Finger Transcription Factor CREB Clin. Cancer Res., Mar 2010; 16: 1423 - 1430 [ZIP4]

The Elk-1 and Serum Response Factor Binding Sites in the Major Immediate-Early Promoter of the Human Cytomegalovirus are Required for Efficient Viral Replication in Quiescent Cells and Compensate for Inactivation of the NF-{kappa}B Sites in Proliferating Cells J. Virol., Feb 2010; 10.1128/JVI.02141-09 [pRS]

HuSH shRNA Cloning Plasmid, pRS Vector (Negative Control)

Cat. No.	Description	Price
TR20003	HuSH shRNA Cloning Plasmid, pRS Negative Control	$ 150

Detailed Fact Sheets on this product are available.

Copyright © 2010 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.